Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CLEC3B as a Prognostic and Immunological Biomarker in Pan-Cancer: Multi-Omics Profiling and Validation in Pancreatic Cancer and Exosomes

1 May 2025

Abstract excerpt

Background: Despite the emergence of in vitro and in vivo experiments validating the connection between CLEC3B and various cancers, a comprehensive pan-cancer investigation remains elusive. In this study, we explored the potential roles of CLEC3B as a tumor suppressor and in immune function across multiple cancer types. Methods: We visualized outcomes derived from Gene Expression Omnibus (GEO) and diverse online...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40416711
DOI: 10.2147/jir.s517595

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CLEC3B as a Prognostic and Immunological Biomarker in Pan-Cancer: Multi-Omics Profiling and Validation in Pancreatic Cancer and ExosomesPMID 40416711Read ↗

Pan-cancer and single-cell analyses reveal LAMP3 as a biomarker associated with cancer prognosis and immune infiltrationSemantic proximity Read ↗

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and PrognosisSemantic proximity Read ↗

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapySemantic proximity Read ↗

Development of a Diagnostic Model for Barrett's Esophagus and Esophageal Adenocarcinoma Based on Machine Learning and Immune InfiltrationSemantic proximity Read ↗

Identification of autophagy-related immune targets for enhancing immunotherapy in pancreatic cancer aggressivenessSemantic proximity Read ↗

Upregulation of B3GNT3 Correlates With Poor Prognosis and Decreased Immune Cell Infiltration In Pancreatic AdenocarcinomaSemantic proximity Read ↗

Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types.Semantic proximity Read ↗

Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung AdenocarcinomaSemantic proximity Read ↗

Comprehensive analysis of long non-coding RNA MAGI2-AS3 as a key immune regulator, therapeutic target and prognostic biomarker across pan-cancer with a focus on colorectal cancerSemantic proximity Read ↗

A multidimensional pan-cancer analysis of CD47 and its role in promoting malignant phenotype in pancreatic adenocarcinoma.Semantic proximity Read ↗

A machine learning-derived immune-related prognostic model identifies PLXNA3 as a functional risk gene in colorectal cancerSemantic proximity Read ↗

Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.